Rhenman & Partners Asset Management AB trimmed its position in Cigna Group (NYSE:CI – Free Report) by 16.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,650 shares of the health services provider’s stock after selling 7,850 shares during the quarter. Rhenman & Partners Asset Management AB’s holdings in Cigna Group were worth $10,638,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of CI. Beacon Financial Strategies CORP acquired a new position in shares of Cigna Group in the fourth quarter valued at $28,000. Lodestone Wealth Management LLC acquired a new position in shares of Cigna Group in the fourth quarter valued at $32,000. Creative Financial Designs Inc. ADV raised its stake in shares of Cigna Group by 147.3% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after purchasing an additional 81 shares in the last quarter. Activest Wealth Management raised its stake in shares of Cigna Group by 1,050.0% in the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 126 shares in the last quarter. Finally, Entrust Financial LLC acquired a new position in shares of Cigna Group in the fourth quarter valued at $42,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on CI shares. Robert W. Baird set a $337.00 price target on Cigna Group in a research report on Friday, May 1st. The Goldman Sachs Group upped their price target on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Sanford C. Bernstein upped their price target on Cigna Group from $358.00 to $371.00 and gave the company an “outperform” rating in a research report on Tuesday, May 5th. Wall Street Zen cut Cigna Group from a “buy” rating to a “hold” rating in a research report on Saturday, June 6th. Finally, Morgan Stanley upped their price target on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research report on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $338.80.
Insider Activity at Cigna Group
In other news, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.
Cigna Group Price Performance
Shares of CI stock opened at $297.77 on Friday. The stock’s fifty day moving average is $282.53 and its 200-day moving average is $278.01. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market capitalization of $78.77 billion, a PE ratio of 12.62, a PEG ratio of 1.14 and a beta of 0.28. Cigna Group has a 52 week low of $239.51 and a 52 week high of $338.89.
Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities research analysts expect that Cigna Group will post 30.39 EPS for the current fiscal year.
Cigna Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is presently 26.45%.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Read More
- Five stocks we like better than Cigna Group
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
